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Abstract. Mature adult parenchymal hepatocytes, typi- 
cally of restricted capacity to proliferate in culture, can 
now enter into clonal growth under the influence of 
hepatocyte growth factor (scatter factor) (HGF/SF), 
epidermal growth factor (EGF), and transforming 
growth factor et (TGFo  0 in the presence of a new chem- 
ically defined medium (HGM). The expanding popula- 
tions of hepatocytes lose expression of hepatocyte spe- 
cific genes (albumin, cytochrome P450 IIB1), acquire 
expression of markers expressed by bile duct epithe- 
lium (cytokeratin 19), produce TGFot and acidic FGF 
and assume a very simplified morphologic phenotype 
by electron microscopy. A major change associated 
with this transition is the decrease in ratio between 
transcription factors C/EBPo~ and C/EBP[3, as well as 
the emergence in the proliferating hepatocytes of tran- 
scription factors AP1, NFKB. The liver associated tran- 
scription factors HNF1, HNF3, and HNF4 are pre- 
served throughout this process. After population 
expansion and clonal growth, the proliferating hepato- 
cytes can return to mature hepatocyte phenotype in the 
presence of EHS gel (Matrigel). This includes complete 
restoration of electron microscopic structure and albu- 
min expression. The hepatocyte cultures however can 
instead be induced to form acinar/ductular structures 
akin to bile ductules (in the presence of HGF/SF and 
type I collagen). These transformations affect the entire 
population of the hepatocytes and occur even when 
DNA synthesis is inhibited. Similar acinar/ductular 
structures are seen in embryonic liver when HGF/SF 
and its receptor are expressed at high levels. These 
findings strongly support the hypothesis that mature 
hepatocytes can function as or be a source of bipoten- 
tial facultative hepatic stem cells (hepatoblasts). These 
studies also provide evidence for the growth factor and 
matrix signals that govern these complex phenotypic 
transitions of facultative stem cells which are crucial for 
recovery from acute and chronic liver injury. 
q 
EVERAL studies in recent years have shown that hepa- 
tocyte growth factor, also known as scatter factor 
(HGF/SF)  1,  EGF  (epidermal  growth  factor),  and 
TGFcx are the primary mitogens for hepatocytes in culture 
which stimulate limited hepatocyte DNA synthesis in chem- 
ically defined media (for review see Michalopoulos, 1990). 
These growth factors, first shown to be hepatocyte mito- 
gens in culture,  were subsequently found to also play a 
role  in  vivo, in liver regeneration  after partial  hepatec- 
tomy. Plasma levels of HGF/SF rise within 30 rain after 
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partial  hepatectomy  (Lindroos  et  al.,  1991). HGF/SF 
mRNA also increases in mesenchymal cells of regenerat- 
ing liver 3-24 h after partial hepatectomy (Zarnegar et al., 
1991), paralleling a rise of TGFet and acidic FGF produc- 
tion in hepatocytes (Mead and Fausto, 1989; Kan et al., 
1989). Injection of HGF/SF, TGFet, or EGF in rats induces 
DNA synthesis in hepatocytes (Liu et al., 1994; Roos et al., 
1995; Bucher et al., 1977; Webber et al., 1994; Ishiki et al., 
1992) directly or after pretreatments  such as collagenase 
or "priming" with nutritional manipulations. 
Liver regeneration is achieved primarily by cell division 
of mature adult hepatocytes (Grisham, 1962). These cells 
(or  a  fraction  of them)  have  a  high  capacity for clonal 
growth,  as  shown  by hepatocyte transplantation  experi- 
ments in ectopic sites (Jirtle and Michalopoulos, 1982) and 
in  transgenic  mouse models  (Rhim  et  al.,  1994). It  has 
been shown, however, that when liver is stimulated to re- 
generate while proliferation of mature hepatocytes is sup- 
pressed,  facultative  stem  cells  emerge  and  proliferate 
(Thorgeirsson et al., 1993; Evarts et al., 1993; Sigal et al., 
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Several names have been used to describe these cells, of 
which the term "oval cells" has prevailed for historical rea- 
sons. These cells can mature into hepatocytes in defined 
animal  models.  Similar  cells,  however,  have  been  de- 
scribed in end-stage human liver disease such as fulminant 
hepatic failure. These cells generate hepatocytes or ductu- 
lar  structures  composed  of cells  (ductular  hepatocytes) 
with mixed hepatocyte and bile  duct epithelial markers 
(Gerber et al., 1983; Vandersteenhoven et al., 1990). While 
the presence of such cells is not doubted, little is known 
about their origin and about the controls regulating their 
phenotypic  transitions  to  hepatocytes or  ductular  cells. 
The capacity of oval cells to generate ductular cells and 
hepatocytes  parallels  the  behavior  of  early  embryonic 
hepatoblasts, which also differentiate toward either hepa- 
tocytes or ductular cells (Fausto, 1994). 
Despite the high capacity of hepatocytes to proliferate 
in vivo, directly or via facultative stem cell growth, the 
conditions that determine their growth potential and their 
phenotypic transitions are not thoroughly understood due 
to the hitherto limited potential for hepatocyte growth in 
primary culture. Typically, under the influence of primary 
mitogens, hepatocytes in primary culture enter into a lim- 
ited number of divisions following which they degenerate 
and die (for review see Michalopoulos et al., 1986). This 
has been associated with changes in gene expression and 
changes in specific transcription factor levels (Rana et al., 
1994). In other culture systems hepatocyte differentiation 
is well maintained but cell proliferation is absent or very 
low (Bucher et al., 1990). The limited capacity of hepato- 
cytes to proliferate in primary culture has hindered appli- 
cations of hepatocyte cultures to cellular transplantation 
and gene therapy. Despite more than twenty years of work 
in this field, there are no culture systems available that al- 
low the population of hepatocytes to expand. 
In this report we document conditions that allow hepa- 
tocytes to enter into sustained clonal growth resulting in 
expansion of the cell population.  A  new chemically de- 
fined hepatocyte growth medium (HGM)  allows such a 
growth under the influence of hepatocyte primary mito- 
gens  HGF/SF, TGFa,  and/or EGF.  Under these  condi- 
tions, hepatocytes undergo multiple proliferative cycles, 
express altered levels of hepatocyte-associated transcrip- 
tion factors and lose characteristic gene expression mark- 
ers (albumin, cytochrome IIB1) while expressing aspects 
of bile duct epithelial phenotype (cytokeratins 14, 19). In 
the presence  of specific matrix components and growth 
factors, these simplified cells (for which we will use the 
term proliferating hepatocytes) either revert to a mature 
hepatocyte phenotype or form acinar structures composed 
of cells with mixed ductular and hepatocytic appearance. 
This paper describes the relative effects of specific mito- 
gens and matrix and the roles they play in phenotypic tran- 
sitions and growth of the proliferating hepatocytes. The 
results provide new insights on the role of the growth fac- 
tors, matrix and nutrients as determinants of hepatocyte 
growth and differentiation. The unexpected phenotypic ef- 
fects induced by each of these signals provide information 
about  the  role  of these  signals  not  only in  control  of 
growth of hepatocytes but also in determining differentia- 
tion of the multiple hepatic lineages (hepatocytic, bile duct 
epithelial, stem cell, etc.) during liver regeneration and de- 
velopment. 
Materials and Methods 
Materials 
Male Fischer 344 rats from Charles River were used for all the experi- 
ments involving hepatocyte isolation. EGF was obtained from Collabora- 
tive Research (Waltham, MA). [3H]Thymidine was obtained from ICN 
Radiochemicals (Irvine CA). Collagenase for hepatocyte isolation was ob- 
tained from Boehringer, Mannheim (Germany). Vitrogen (from Celtrix 
Labs., Palo Alto, CA) was used for the construction of the collagen gels. 
General reagents were obtained from Sigma Chem. Co. (St. Louis, MO). 
EGF and Matrigel were purchased from Collaborative Research. HGF/SF 
used for these studies was the A5 variant and was kindly donated by Snow 
Brand Co (Toshigi, Japan). ECL was purchased from Upstate Biotechnol- 
ogy (Lake Placid, NY). 
Isolation and Culture of  Hepatocytes 
Rat hepatocytes were isolated by an adaptation of the calcium two step 
collagenase perfusion technique as previously described from our labora- 
tory (Kost and Michalopoulos, 1991). Hepatocytes were plated on a single 
layer of collagen gel (see below) and left to attach for 2 h. Six-well cluster 
plates (9.8 square centimeters per plate) from Coming (Ithaca, NY) were 
used. Unless otherwise specified, 10,000 hepatocytes per square centime- 
ter surface were inoculated for all the experiments described. The medium 
was changed at 2 h after cells were plated and every 48 h thereafter. Thy- 
midine, growth factors, etc., were added at the time of medium change as 
required. 
Human hepatocytes were isolated by an adaptation of the collagenase 
perfusion technique as described previously from our laboratory (Strom 
et al., 1982). Cells were cultured as described above for the rat hepatocytes. 
Matrix Manipulations.  Collagen gels were prepared  as we previously 
described (Michalopoulos and Pitot, 1975). Dry coating of plates with col- 
lagen and Matrigel was also done as previously described. Matrigel gels 
were made by adding 50 ixl of Matrigel solution into 0.5 ml of medium di- 
rectly on top of attached cells. 
DNA  synthesis was measured by uptake  of tritiated  thymidine into 
TCA precipitable material as previously used in our laboratory (Kost and 
Michalopoulos, 1991).  Collagen gels, where necessary, were digested with 
2 mg of collagenase per ml of MEM medium. Incubation was done for 30 
rain at 37°C. The digested gels were treated with NaOH followed by TCA 
to precipitate DNA, RNA, and proteins as previously described (Kost and 
Michalopoulos, 1991). 
Composition of  the HGM Medium 
DMEM, Hepes, glutamine, and antibiotics were purchased from GIBCO/ 
BRL (Gaithersburg, MD). ITS mixture (Insulin, Transferrin, Selenium) 
was purchased from Boehringer Mannheim. All other additives were cell 
culture  grade  (Sigma).  Unless otherwise  indicated  for  specific experi- 
ments, the basal HGM medium consisted of DMEM supplemented with: 
purified bovine albumin 2.0 gm/L, glucose 2.0 gndL, galactose 2.0 grrdL, 
ornithine 0.1 gin/L, proline 0.030 gm/L, nicotinamide 0.610 gin/L, ZnCI2 
0.544 rag/L, ZnSO4:7H20 0.750 nag/L, CuSO4:5H20 0.20 rag/L, MnSO4 
0.025 rag/L, glutamine 5.0 mM, ITS 1.0 gin/L, (rh-insulin 5.0 rag/L, human 
transferrin 5.0 mg/L [30% diferric iron saturated], selenium 5.0 p,g/L), and 
dexamethasone 10  -7 M. Penicillin and streptomycin were  added to the 
basal HGM at  100  mg/L and  100 rag/L, respectively. The mixed basal 
HGM was sterilized by filtration through a 0.22-p,m low protein-binding 
filter system, stored at 4°C, and used within 4 wk. The growth factors, as 
required, were added to HGM fresh at the specified concentrations every 
time the medium was changed. 
Retroviral Transfection and Assessment 
of Clonal Expansion 
Hepatocytes were initially plated at 104/cm  2 and grown in HGM supple- 
mented with HGF/SF (40 ng/ml) and EGF (20 ng/ml). After 68 h the media 
was  replaced  with  supernatant  from  CROP-packaged,  replication- 
deficient, amphotropic retrovirus (MFG, ~5 x  105 units per ml) contain- 
ing the E. coli 13-galactosidase  gene under an LTR promoter as previously 
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natant was replaced after 18 h with HGM (with EGF 20 ng/ml, HGF/SF 
40 ng/ml). The brief exposure with the virus containing supernatant did 
not have an adverse effect on hepatocyte survival or proliferation. At indi- 
cated times, cells were fixed with 0.5% glutaraldehyde in PBS for 10 min 
and developed with X-Gal substrate at 37°C for 16 h. Transduced ceils ex- 
pressing the E. coil gene stained blue as shown. Appropriate controls for 
each component were negative for X-Gal staining. 
Transmission Electron Microscopy 
Samples for transmission electron microscopy (TEM) were fixed on the 
culture plates for 1-1.5 h in 0.1 M sodium cacodylate buffer (pH 7.4) con- 
taining 2.5% glutaraldehyde and 2% formaldehyde. The plates were then 
rinsed 2× with 0.1 M sodium cacodylate buffer (pH 7.4) and 2x with 0.1 M 
sodium cacodylate buffer containing 5% sucrose (pH 7.4). They were held 
in the sucrose buffer for 1-7 d, rinsed 2x with 0.1 M  sodium cacodylate 
buffer (pH 7.4), and then postfixed for 1 h in 1% OsO4 in 0.1 M  sodium 
cacodylate buffer. The plates were then rinsed again in buffer, and the 
fixed and processed collagen gels were cut in strips with a razor blade. The 
strips  were  transferred  to  glass specimen vials, dehydrated  through  a 
graded series of ethanol (25-100%) and two propylene oxide changes, and 
infiltrated with Epon-Araldite resin. Several changes of resin were made 
over 2 d, as the collagen gels tended to hold the propylene oxide. The col- 
lagen strips were flat-embedded and cured overnight at 60°C. 
Nuclear Extract Preparation 
Nuclear extracts were prepared as described (Chiles et al., 1991; Dignam 
et al., 1983;  Wen and Locker, 1994)  with several modifications. All cell 
culture preparations were based on initial plating of 6 x  106 cells in 100- 
mm plates. Cells were scraped from the plates; washed in 40 mM Tris, pH 
7.6, 14 mM NaCI, 1 mM EDTA; resuspended in 2 ml of hypotonic buffer 
(10 mM Hepes, pH 7.9, 1.5 mM MgCl2, 0.5 mM spermidine, I mM DTT, 1 
mM PMSF, and 1 ixg/ml each of leupeptin, aprotinin, and antipain, plus 
I%  nonfat dry milk [Tian and Schibler, 1991]);  incubated for 10 min at 
4°C; and given 60-100 strokes in a  Dounce homogenizer. Homogenates 
were examined under a microscope to control breakage. Released nuclei 
were pelleted by centrifugation at 800 g for 5 min, washed, and extracted 
in 50 pxl of hypertonic extraction buffer (30 mM Hepes, pH 7.9, 25% glyc- 
erol, 450 mM NaCI, 0.3 mM EDTA, 6 mM DT'I', 12 mM MgClz, 1 mM 
PMSF, and 1 ~g/ml each of leupeptin, aprotinin, and antipain) for 45 min. 
After centrifugation at 40,000 g for 30 min, the supernatant was recovered 
and dialyzed for 2  h  against the same solution, but containing 150 mM 
NaC1. Protein concentration was determined with the BioRad protein as- 
say kit (Bradford, 1976). Preparations yielded from 60 to 130 p.g protein. 
Gel Shift Assays 
Single stranded oligonucleotides (Table II) were annealed by incubation 
at 65°C for 15 min followed by slow cooling to room temperature. Label- 
ing was performed by incubating the double-stranded oligonucleotides 
with 2  U  Klenow DNA polymerase I,  20  p~Ci each  of [32p]dCTP  and 
a-[32p]dATP (each 650 Ci/mmole), in 50 nM dGTP, 50 nM dTTP, 10 mM 
Tris, pH 7.5, 5 mM MgCI2, 7.5 mM DTT at 37°C for 60 rain. After phenol 
extraction, the unincorporated nucleofides were removed using a  G-50 
Sephadex mini column. Specific activities were ~5  x  107 counts/min/~g. 
The binding reactions (10 ~1) contained 2 ng of double-stranded oligonu- 
cleotide probe, 5 p~g poly(dI-dC):poly(dI-dC), and 2.1 (AP1, NF1) or 4.2 
p.g (C/EBP,  HNF1, HNF3, HNF4, NFKB) nuclear extract protein in 25 
mM Hepes, pH 7.9,  100 mM NaCI, 9 mM MgC12, 0.25 mM EDTA, 18% 
glycerol, 5 mM DTT, 0.75 mM PMSF, and 0.75 p~g/ml each leupeptin, anti- 
pain, and aprotinin. After a 20-rain incubation at room temperature, the 
mixture was electrophoresed through a  6% polyacrylamide gel in 0.5  x 
TBE running buffer for 1.5 h. For supershifts, 2 ILl of antibody to C/EBPa 
or C/EBP[3 (Santa Cruz Biotechnology, Santa Cruz, CA) was added to the 
reaction after 20 min, which was incubated for an additional 1 h at room 
temperature  before  electrophoresis.  Gels  were  dried  and  autoradio- 
graphed. 
Analysis of Gene Expression by Northern Blots 
Extraction of Total RNA and mRNA from Cultures. Total RNA was extracted 
from unwashed cell cultures using 2.0 ml of RNAzol B (Cinna/Bio TECX 
Laboratories, Houston, TX) per well and purified per the manufacturer's 
guidelines. RNA concentration and purity were determined by routine 
spectrophotometry. Size separation  of 20 ~g RNA per  lane was com- 
pleted  on denaturing  1%  agarose gels and transferred to  nylon mem- 
branes (Amersham, Arlington Heights, IL) by the capillary method. After 
cross-linking under UV light, membranes were hybridized overnight with 
specific cDNAs (as indicated in the figures) that had been labeled with [ct- 
3Zp]dCTP  using an Amersham random primer kit. Membranes were sub- 
sequently washed under high stringency conditions and exposed to R film 
(Kodak, NY) for 1-3 d. Quantification of the RNA hybridization bands 
was performed by laser densitometry. 
Sources of  cDNA Probes 
eDNA probes used to study gene expression were obtained from the fol- 
lowing sources: Cytokeratin 8 from Dr. Norman Marceau (Laval Univer- 
sity, Quebec City, Canada); Cytokeratin 14 from Dr. Dennis Roop (Bay- 
lor College of Medicine, Houston, TX); Cytokeratin 18 from Dr. Robert 
Oshima (La Jolla Cancer Research Foundation, San Diego, CA); Cyto- 
keratin 19 from Dr. Andr6 Royal (University of Montreal, Montreal, Can- 
ada); TGFa  (rat)  originated from Dr.  David Lee (University of North 
Carolina at Chapel Hill); EGF-R (rat) originated from Dr. Sheldon Earp 
(University of North Carolina at Chapel Hill); aFGF from Amer. Type 
Culture Collection (catalog No. 78222); aFGF-R from ATCC, Rockville, 
MD (catalog No. 65796);  uPA originated from Dr. Jay Degen (University 
of Cincinnati, Cincinnati, OH); cytochrome IIB1 from Dr.  Steve Strom 
(co-author); cDNAs for albumin, c~ fetoprotein, and transcription factor 
analysis were generated by Dr. Joe Locker (co-author). 
In situ Hybridization 
In situ hybridizations were performed as described (Shiratori et al., 1995). 
HGF/SF eDNA and c-MET eDNA with flanking T3 and SP6 RNA poly- 
merase  promoters  were  prepared  by  RNA-polymerase chain  reaction 
(Frohman, 1990), using rat lung poly(A) + RNA and sense strand primers 
(HGF/SF: nucleotides 282-303 [Tashiro et al., 1990]); c-MET: nucleotides 
2913-2932 [Chan et al., 1988])  and antisense strand primers (HGF/SF: nu- 
cleotides 649-670; and c-MET:  nucleotides 3362-3383). 3Up-labeled  anti- 
sense and sense riboprobes were synthesized using SP6 or T3 RNA poly- 
merases and the Riboprobe Gemini Core System II transcription kit from 
Promega  (Madison, WI).  Embryos were  collected  at  16 d  of gestation 
from timed-pregnant rats. The embryos were fixed in 4% formaldehyde. 
10-1~m-thick sections were cut and placed on aminopropyltriethoxysilane- 
coated slides. The slides were rinsed in PBS, treated with proteinase K (1 
p.g/ml), and acetylated with acetic anhydride (0.25%, vol/vol, in 0.1 M tri- 
ethanolamine, pH 8). 
Hybridization with sense and antisense probes, washing of the slides, 
and emutsion-autoradiography were performed as described (McLaughlin 
and Margolskee, 1993). 
Results 
Role of  Media Components and Matrix Substrates on 
Cell Proliferation 
The full description of the HGM medium is given in the 
Materials  and Methods.  To evaluate the relative impor- 
tance of the different media components several experi- 
ments were performed whose results are shown in Table I 
(A, B, and  C). The components glucose, albumin,  dexa- 
methasone,  transferrin  and  selenium,  nicotinamide,  and 
trace elements were individually subtracted from the full 
medium composition (Table I A). The total DNA per cul- 
ture after 14 d of growth is shown. Removal of dexametha- 
sone had the most dramatic effect, followed by removal of 
nicotinamide. In Table I B, growth of cells achieved by day 
14 is compared between HGM medium containing diferric 
transferrin (iron saturated) vs iron unsaturated transferrin. 
Addition of iron containing diferric transferrin (30% satu- 
ration) was much more effective in promoting growth. Ad- 
dition of elemental iron (FeSO4, 0.1  IxM) to the unsatur- 
ated transferrin failed to overcome the difference. Table I 
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A. Effect of removal of specific HGM components on hepatocyte growth 
Zero time DNA  13.90 ±  3.60 
DNA at day 14 in HGM (with HGF/SF and EGF) supplemented with: 
+All components  84.90 ±  0.50 
-Glucose  69.80 ±  2.90 
-Albumin  68.70 _+ 0.50 
-Dexamethasone  13.70 +_ 0.20 
-(Transferrin and selenium)  63.10 --_ 2.00 
-Nicotinamide  35.20 ±  1.70 
-Trace elements  65.00 ±  2.40 
-All components  20.20 ±  4.30 
B. Effects of iron and transferrin  on hepatocyte growth 
Zero time DNA 
Diferric transferrin (iron saturated) 
Diferric transferrin plus added iron (5 I~M) 
Iron poor transferrin 
Iron poor transferrin with added iron 
9.21  _+  1.01 
70.15 --_  1.21 
1.83 ±  0.41 
24.84 ±  4.30 
1.10 -- 0.90 
C. Effect of removal of glucose, omithine, or galactose 
Zero time  11.0 +  0.4 
Control (Gluc.+, Ore.+, Gal.+)  59.0 -  2.5 
Gluc.-,Orn.-,Gal.-  10.6 ±  0.8 
Gluc.-,Om.+,Gal.-  14.4 _+ 0.9 
Gluc.-,Orn.-,Gal.+  44.2 -4- 6.0 
Gluc. +,Om.-,Gal.-  59.0 ±  4.0 
Gluc.+,Orn.+,Gal.-  62.7 ___  1.4 
Gluc.+,Om.-,Gal.+  63.6 +  0.3 
The indicated HGM components were removed and hepatocytes grew in the modified 
media for 14 d. The total DNA per culture in micrograms was measured at day 14 to 
evaluate cell growth. Time zero was the sample of hepatocyte suspension that was in- 
oculated into the plate immediately after cell isolation. The data are expressed as mean 
-+ standard error of three separate plates. 
C provides information on the relative effects of glucose, 
galactose, and ornithine.  All three of these components 
are potential sources of energy to the cells. Complete ces- 
sation of growth was noticed when all three were removed. 
Addition of glucose alone restored most of the response 
whereas addition of galactose alone was less effective. Or- 
nithine  alone had minimal effect. Concentrations of 2  g 
per liter each of albumin and glucose were found to be op- 
timal  though  the  effects were  not  statistically  different 
than 1 or 3 g per liter in each case. The effect of complete 
removal of these components was shown in Table I A. 
Several matrix substrates promoted cell growth in this 
system. Dry coating with collagens type IV (mouse), type I 
(bovine), fibronectin, and laminin were equally effective 
in promoting cell growth as assayed by measurement of to- 
tal DNA per culture at day 14. Dry coating with ECL (a 
commercial derivative of EHS gel, UBI) had in some cul- 
tures  superior  effects but  the  effect was  not  consistent 
(data not shown). Coating with type I collagen (Vitrogen 
commercial preparation) was  the  standard  method used 
for the subsequent experiments unless otherwise specified. 
The effect of matrix gels in promoting specific phenotypic 
conversions in these cultures is discussed below. 
Hepatocytes Enter Diffusely into Proliferation under 
the Influence of HGFISF, EGF, and TGFa 
Fig.  1 (A and B) shows the uptake of thymidine per Ixg 
DNA, as well as the BRdU nuclear labeling index at dif- 
ferent days in culture in cells growing in the presence of 
HGF/SF  and  EGF.  Most  of the  proliferation occurs  at 
days  5-12.  By  day  15  the  cultures  were  confluent  and 
DNA synthesis slowed down. The high nuclear labeling in- 
dex during the times of sustained proliferation documents 
that the proliferating cells are  not  a  minor contaminant 
population but they derive directly from the mature pa- 
renchymal hepatocytes (see Discussion). 
The growth factors HGF/SF, EGF, TGFa, KGF, SCF, 
and aFGF were added individually to HGM medium. Of 
the growth factors added, only HGF/SF, EGF, and TGFa 
caused significant cell proliferation, as shown by the total 
amount of DNA per culture at day 15. Keratinocyte growth 
factor (KGF), acidic fibroblast growth factor (aFGF), and 
stem cell factor (SCF) when added alone or in combina- 
tion had no effect (data not shown). TGFa had a stronger 
proliferative effect than any of the other mitogens added 
alone. HGF/SF and EGF together had the strongest prolif- 
erative effect altogether than any other single mitogens or 
combinations. Addition of all the growth factors together 
had no more effect than the combined HGF/SF and EGF 
(data  not  shown).  The detailed cell kinetics induced by 
HGF/SF and EGF alone or in combination are shown in 
Fig. 1 C. The total DNA per culture is shown as a function 
Table I1. Oligonucleotiges ,Used in the Gel Shift Studies 
Factor  Oligonucleotide  Reference 
C/EBP  tc gaATCTTACTCAACAT  (Costa et al., 1988; Locker, J., unpublished) 
TAGAATGAGTTGTAagc  t 
HNFI  t  c  gaTGTGGTTAATGATCTACAGTTA  (Brunel  et  al.,  1988) 
ACAC  CAATTACTAGATGTCAATagc  t 
HNF3  tc gaAGTTGACTAAGTCAATAATCAGAATCAG  (Costa et al., 1989) 
T  CAACTGATTCAGTTATTAGTCTTAGTC  a  gc  t 
HNF4  t  c  gaGCGCTGGGCAAAGGTCACCTGC  (Sladek, 1990) 
CGCGAC  CCGTTTCCAGTGGACGa  gc  t 
APt  tc  gaAGGGG:CCATGTGACTCATTACACCAG  (Xanthopoulos,  1991) 
TCCCCGGTACACTGAGTAATGTGGTC  a  gc  t 
NFKB  t  c  gaTCGAGGGCTGGGGATTCCCCATCTC  (Tewari, 1992) 
AGCTCCCGACCCCTAAGGGGTAGAGagc  t 
NFI  tcgaATTTTGGCTTGAAGCCAATATG  (Nakabayashi et  al.,  1991) 
TAAAACC  GAACTT  C  GGTTAT  AC  a  g  c  t 
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Figure 1.  (A) Labeling index (BRdU) of proliferating cultures at 
different times after hepatocyte isolation.  Cells were exposed to 
HGF/SF  and  EGF  in  HGM  medium.  (B)  Incorporation  of 
[aH]thymidine into DNA in cultures at different times after hepa- 
tocyte isolation.  Cells  were  exposed to HGF/SF and  EGF in 
HGM medium. Symbols: Control: VI; HGF/SF: ©; EGF: O; HGF/ 
SF+EGF: A. (C) Amount of DNA per plate at different  days in 
culture as indicated.  Cells were kept in HGM and exposed to the 
indicated growth factors at the concentrations stated in Materials 
and Methods.  Control:  [3; HGF/SF: •;  EGF: V; HGF/SF+EGF: 
0. All points represent the mean and standard error of at least 
three separate cultures. 
of the time in culture. The largest amount of accumulated 
DNA at day 15 was seen with the combination of HGF/SF 
and EGF. The DNA per culture  at day 15 was 12 times 
that at time 0, reflecting the increase in cell number. HGF/ 
SF and EGF were equally potent. Again TGFct alone was 
more  mitogenic  than  either  HGF/SF  or  EGF  alone. 
Whereas, however, HGF/SF and EGF synergized, no such 
synergism was  seen with  HGF/SF  and  TGFot  (data  not 
shown). 
Phenotypic Changes of Hepatocytes 
during Proliferation 
The morphology of the proliferating cells varied at differ- 
ent  times  after stimulation  of cell proliferation.  From  a 
normal hepatocyte morphology at day 1  (Fig.  2 A), the 
proliferating cells in the first 4 d acquired long projections 
assuming the phenotype typically described as due to the 
"scattering" effect of HGF/SF on hepatocytes (Fig.  2 B) 
(Michalopoulos et al., 1993). Between days 6 and 8 (Fig. 3 
A)  the  proliferating cells  lost most  of their  cytoplasmic 
granules,  the  nuclei  became less prominent,  the  projec- 
tions diminished and the cells began to grow as monolayer 
patches. Eventually these patches merged as the cells con- 
tinued to grow to form a continuous monolayer (Fig. 2 C). 
Examination  by electron  microscopy (Fig.  2  D,  and  E) 
showed that most of the features typical of mature hepato- 
cytes were missing. By day 15 there were no lamellae of 
endoplasmic  reticulum  wrapping  around  mitochondria 
and there  are no glycogen rosettes or peroxisomes. Bile 
canaliculi  are  absent.  There  is  a  prominent  increase  in 
bundles of keratin intermediate filaments. The nuclei were 
angular with very prominent nucleoli. This morphology re- 
mained stable for several months. The overall size of the 
cells became smaller with increasing days in culture as the 
cells continued to proliferate. No noticeable differences in 
electron microscopic morphology or percent of nuclear la- 
beling with BRdU were noticed based on cell size. 
Clonal growth of the proliferating hepatocytes is dem- 
onstrated in Fig. 2, F and G. Hepatocytes were transfected 
at day three in culture with a replication-deficient retrovi- 
rus containing the lac-Z gene under the influence of a viral 
LTR and stained for expression of I~-galactosidase. Mostly 
single cells were stained positive at day four in culture (1 d 
after transfection). On the other hand, staining at day 10 
and  continuing  through  day  28  showed  predominantly 
patches  of hepatocytes,  suggesting  clonal  growth  of the 
original  (single  cell)  transfected  hepatocyte  precursors. 
The percentage of lac-Z--positive cells (~20%) did not ap- 
pear to change during culture (data not shown). 
Proliferating Hepatocytes Lose Hepatic 
Differentiation Markers and Produce TGF~ and aFGF 
and Cytokeratin 19 
The  expression of several specific genes was  assayed in 
proliferating  hepatocytes.  These  included  mRNA  genes 
associated with hepatocyte differentiation (albumin, cyto- 
chrome IIB1), genes encoding cytokeratin markers (cyto- 
keratins  14,  18,  and  19)  or related to hepatocyte growth 
(urokinase  [uPA],  HGF/SF and its receptor c-met, EGF 
and TGFot and their receptor, acidic FGF and its receptor, 
and TGFI31). These genes were studied by Northern blot 
analysis of RNA from cultures grown in the presence of ei- 
ther  combined HGF/SF  and  EGF or with  TGFa  alone. 
The results are shown in Fig. 3. Total RNA was isolated 
from cultures at days 0, 6, 10, 15, and 21. No expression of 
Block et al. Hepatocyte  Growth, Biomatrix and Growth Factors  1137 Figure 2.  (A) Hepatocytes in HGM medium with HGF/SF and EGF at day 1 after isolation showing typical nonproliferating  hepatocyte 
morphology. (B) Hepatocytes at day 4 in culture showing the typical scattered morphology induced by HGF/SF. (C) Cultures at day 15 
showing the typical proliferating hepatocyte morphology with clear cytoplasm, small size, and compact monolayer formation. Photomi- 
crographs of cells in Fig. 2, A, B, and C were taken with under phase contrast microscopy, at a magnification  of 100. (D and E) Electron 
micrographs of cells at day 15 in culture, in the presence of HGF/SF and EGF. Note the absence of features typical of hepatocyte cyto- 
plasm (contrast to Fig. 5, B and (7) and the presence of prominent nucleoli, bundles of keratin intermediate filaments (F) and sparse mi- 
tochondria. (F and G) Phase contrast photomicrographs of cultures transfected at day 3 with a lac-Z-containing  replication defective 
retrovirus (for details see Materials and Methods). Cells were stained for ~-galactosidase expression and photographed at days 1 and 10 
after transfection. Mostly single cells are seen at day 1 whereas at day 10 typically patches of multiple positive cells were present. Magni- 
fication, 100. Bars: (D and E) 5 Ixm. 
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ent days in cultures  maintained in HGM in the 
presence of HGF/S and EGF. The expression  of 
the  specific  genes  indicated  was  assessed  by 
Northern  gels  as  indicated  in  Materials  and 
Methods.  GAPDH expression  and the intensity 
of the 28S RNA after ethidium bromide staining 
were used  as internal  controls to compare the 
amount of loaded RNA between lanes. 
HGF/SF or TGFI31 was seen at any of the time points ex- 
amined. 
Albumin and cytochrome IIB1 mRNA were present at 
time zero  and  subsequently decreased.  Albumin mRNA 
appeared again at day 21 at which time mRNA for a  feto- 
protein was also detected, mRNA for cytokeratins 14, 18, 
and  19 increased through culture. There was a  steady in- 
crease in mRNA for aFGF and TGFa. The mRNA of re- 
ceptors for HGF/SF and aFGF remained present through- 
out the culture time. The EGF receptor mRNA declined 
from day zero but remained expressed. GAPDH mRNA 
expression was used as a reference "housekeeping" gene. 
Dramatic increases were noted in expression of urokinase 
as well as cytokeratins 14 and  19.  Some differences from 
the above pattern were seen in the cultures that, instead of 
HGF/SF  and  EGF,  were  maintained  in  the  presence  of 
TGFa.  In these  cultures  albumin expression and expres- 
sion  of  the  HGF/SF  receptor  were  better  preserved 
whereas AFP appeared earlier. Despite the observed dif- 
ferences in gene expression patterns no morphologic dif- 
ferences were seen between cells growing in the presence 
of TGFet of HGF/SF plus EGF. 
Proliferating Hepatocytes  Lose C/EBPa but Express 
Increased Levels of  APl and NFrB While Maintaining 
Other Hepatocyte Transcription  Factors 
To evaluate the  controls which  maintain the  hepatocytic 
phenotype, transcription factors were analyzed in nuclear 
extracts  prepared  from  cultures  maintained  in  HGF/SF 
and  EGF  (for  details  see  Materials  and  Methods).  Gel 
shift assays (Fig. 4) were performed to assess hepatocyte- 
enriched transcription factors C/EBPot, HNF1, HNF3, and 
HNF4; general factors associated with proliferation, such 
as AP1 and NFKB; and NF1, a family of housekeeping fac- 
tors. Extracts from 1-, 5-, 11-,  15-,  and 20-d cultures were 
compared to  freshly isolated hepatocytes. The latter  did 
not  differ  significantly  from  intact  liver  (data  not  illus- 
trated). The day 1 extracts showed a marked alteration of 
several factors that did not persist and by day 5  a  stable 
pattern was established that persisted through day 20. The 
day 1 pattern presumably represents a response to hepato- 
cyte isolation and culture; the most important features of 
this  pattern  are  marked  elevation  of C/EBPo~,  C/EBPI3, 
and AP1, and decrease of HNF4. The day 5 pattern can be 
considered  a  transition  to  the  stable pattern,  which  dif- 
fered qualitatively from time 0 hepatocytes as follows: (a) 
strong  expression  of AP1  and  NFKB;  (b)  a  marked  in- 
crease in HNF4, mostly attributed to the appearance of a 
second band just above the usual HNF4 band shift; and (c) 
decrease of C/EBPa after day 1. Other factors showed rel- 
atively minor  differences  from  hepatocytes.  Because  of 
possible variation in the efficiency of factor extraction in 
the different preparations, factor levels were compared di- 
rectly and also normalized to NF1 as a possible unchang- 
ing internal control (e.g., compare the HNF1 and NF1 pat- 
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scription  factors in proliferat- 
ing hepatocyte cultures. The il- 
lustrated analyses were carried 
out  on  a  single  series  of cul- 
tures  established  at  the  same 
time  and  collected  as  single 
preparations  on days 1, 5,  11, 
15,  and  20.  Day 0  represents 
the  preparation  of  primary 
hepatocytes  used  to  establish 
the  cultures.  Each  individual 
series used matched concentra- 
tions  of nuclear  extract  pro- 
teins.  (A) C/EBP analysis. The 
panels  show  a  standard  gel 
shift  (upper)  and  supershift 
patterns using antibodies to C/ 
EBPct  (middle)  or  C/EBPi3 
(lower).  The  patterns  repre- 
sent  C/EBPet  and  C/EBPI3 
homo- and heterodimers,  and 
other  less  abundant  C/EBP 
family  members.  The film  ex- 
posure was reduced in the upper panel. (B) Other liver-enriched factors. Standard gel shifts for the HNF1 family (HNFlet and 13 homo- 
and heterodimers); HNF3 family (predominantly HNF313); and HNF4. (C) Factors expressed in most cell types. Gel shifts for AP1, 
NFKB (p65:p50 and p50:p50), and NF1 (multiple factors). For B and C, exposures were optimized for each individual series. 
terns).  This  normalization  did  not  alter  the  qualitative 
description. The stable pattern characteristic of the hepa- 
tocytes in HGM medium with HGF and EGF is consistent 
with  a  proliferating  cell  population  (elevated  AP1  and 
NFKB) that shows strong expression of the factors associ- 
ated  with  the  differentiated  hepatic  phenotype  (HNF1, 
HNF3, HNF4, and C/EBPI3) except for C/EBPa. 
Proliferating Hepatocytes Revert to Mature 
Hepatocytes under the Influence of  Matrigel or in the 
Presence of Nonparenchymal Cells 
In confluent  cultures  maintained  longer  than  60  d  there 
was focal overgrowth of fibroblast-like  cells.  Though the 
nature  of these  cells  is not clear,  it has been shown that 
these cells are derived mostly from hepatic Ito cells (Ma- 
her et al., 1988). In those areas, the cytoplasm of the hepa- 
tocytes became  gradually  more  granular.  Within  one  to 
two  weeks  following  this  change,  typical  parenchymal 
hepatocytes were noted, with granular cytoplasm, promi- 
nent bile  canaliculi  (LeCluyse  et  al.,  1994),  bright round 
nuclei, and prominent nucleoli. We assume that this rever- 
sion was dependent  on new matrix  synthesized by fibro- 
blast-like  cells (Maher  et al.,  1988), although soluble fac- 
tors elaborated by fibroblast/Ito cells might also contribute. 
Previous  studies  (Bissell  et  al.,  1987)  have  shown  that 
hepatocytes  maintained  their  differentiated  phenotype 
when kept in Matrigel (a commercial derivative of matrix 
extracted  from  the  EHS  mouse  sarcoma).  This  matrix 
preparation  has high laminin content, but it also contains 
type IV collagen, entactin, decorin, TGF~I and glycosami- 
noglycans,  and  several  growth  factors,  including  TGF~31 
(Kleinman  et  al.,  1982).  When  Matrigel  was overlaid  on 
cultures at day 8, there was a rapid (within 2 d) appearance 
of bile canaliculi and organization of the cells along plate 
structures.  The features of these cells are shown in Fig. 5 
A. By electron microscopy (Fig. 5, B and C) these cells had 
typical markers of mature hepatocytes, including wrapping 
Figure 5.  (A) Phase contrast photomicrograph of cultures of proliferating hepatocytes overlaid with Matrigel at day 8 and photo- 
graphed at day 18 (10 d after overlay of the Matrigel). Note the granular cytoplasm and the appearance of typical bile canaliculi  (bright 
lines between cells) (LeCluyse et al., 1994). Contrast the appearance of these ceils with those of Fig. 2 C. (B and C) Low and high power 
electron photomicrographs of cells at day 18 in culture, 10 d after overlay with Matrigel.  Note the presence of typical features of hepato- 
cyte cytoplasm such as lamellae of endoplasmic reticulum wrapping around mitochondria, microbodies with crystalline center, bile 
canaliculi  (c) abundant mitochondria (M), and (in 5 c) glycogen (G). Contrast with the cytoplasmic features of the cells in Fig. 2, D and 
E. (D) Increased expression of albumin mRNA after addition of Matrigel.  Albumin mRNA is expressed in control cultures (immedi- 
ately after isolation from liver by collagenase perfusion and before culture). Expression is minimal at day 8 in culture. At days 3 and 7 
after Matrigel addition (lanes marked with  +), there was an increase in expression of albumin mRNA. Such increase was not noted in 
control cultures (lanes of days 3 and 7 not marked with +). (E) Induction of cytochrome IIB1 mRNA in cultures treated with Matrigel 
and exposed to Phenobarbitol (PB). Matrigel was added to the cultures at day 8. PB was added 2 d later (day 10 of culture). The cells 
were harvested 5 d after addition of PB (day 15 in culture). GAPDH expression was used as internal control for mRNA loading. (F) Cy- 
tokeratin 19, a bile duct marker expressed by the nondifferentiated proliferating hepatocytes, is suppressed by addition of Matrigel. 
Matrigel was added at day 8 in culture. Control cultures did not receive Matrigel.  CK19 is suppressed by Matrigel while it continues to 
be expressed by control cultures.  (G) Matrigel modifies transcription factor expression.  C designates  a culture grown in collagen for 18 d; 
M, a matched culture to which Matrigel was added on day 10. Gel shifts were used for comparison of transcription factors. Each compar- 
The Journal of  Cell Biology,  Volume 132, 1996  1140 ison shows matched concentrations of nuclear extract proteins. Note that Matrigel induces a small decrease in AP1 and HNF4 expres- 
sion, a small increase in the upper NFKB band, and a marked reduction of C/EBP species. Supershift analysis was used to distinguish be- 
tween the different species of C/EBP. Protein concentrations were modified to show band shifts of approximately equal strength; the 
preparations  are otherwise the same as in A. Antibodies to C/EBPa and C/EBP showed clear supershifting in both preparations and 
densitometric analysis showed similar proportions of C/EBPa and C/EBPI3 in both. Note a lower gel shift band which does not super- 
shift with either antibody. This unidentified C/EBP species is increased in the Matrigel nuclear extract. Bars: (B) 5 ~m; (C) 2 p.m. 
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canaliculi,  and  presence  of  glycogen.  Preparations  of 
mRNA were made from cultures exposed to Matrigel for 
10 d (days 8-18 in culture). The expression of albumin was 
compared between day zero in culture (immediately after 
collagenase  perfusion),  at  day 8  in  culture  (before the 
overlay by Matrigel),  and  cultures at  day 3  and 7  after 
Matrigel overlay (Fig. 5 D). Addition of Matrigel had dra- 
matic  increases  in  expression  of albumin  mRNA,  com- 
pared to control cultures in which it was barely detectable. 
We also measured the effect of Phenobarbitol (PB) on the 
levels of cytochrome P450 IIB1 mRNA in the Matrigel- 
treated cultures (Fig. 5 E). Matrigel was added to the cul- 
tures at day 8. PB was added 2 d later (day 10 of culture). 
The cells were harvested 5 d after addition of PB (day 15 
in  culture).  Addition  of  PB  induced  cytochrome  IIB1 
mRNA only in the Matrigel-treated cultures. Induction of 
this mRNA by phenobarbitol is typical of hepatocytes and 
does  not  occur in  any other cell  (Michalopoulos  et  al., 
1976). Typically most hepatocyte cultures lose the capacity 
to respond to PB. This finding is additional evidence that 
addition of Matrigel to the cultures of proliferating hepa- 
tocytes  induces  a  mature  hepatocyte phenotype,  as  at- 
tested by the electron microscopic structure shown in Fig. 
5, B  and C). The expression of cytokeratin 19 (CK19), a 
bile duct marker (Sirica 1992, 1995) expressed by the pro- 
liferating  hepatocytes before  introducing  differentiating 
conditions (Fig. 3 B), also ceased after addition of Matri- 
gel, in contrast to the differentiation toward ductular lin- 
eage (see Fig. 6 E below) in which CK19 continued to be 
expressed  even  in  nonproliferating  ductular  cells.  The 
above changes in gene expression patterns were assessed 
by detection of the expression of the specific mRNA. The 
presence of the actual proteins was not directly assessed. 
The presence of these proteins is  reasonable to assume, 
but not directly proven. Transcription factor changes were 
also assessed and the results are shown in Fig. 5 F. Matri- 
gel induced a marked reduction in C/EBP expression and 
a smaller decrease in HNF4 and AP1 expression. The re- 
duced C/EBP[3 expression represented a  reversion from 
the high level of the cells cultured on collagen to the level 
observed in normal hepatocytes; however, the expression 
of C/EBPa was considerably lower than in normal hepato- 
cytes. This is  in  contrast with  other previous studies  in 
which increased differentiation of hepatocytes was associ- 
ated with increased levels of C/EBPet (see Discussion). 
We measured DNA synthesis in the cultures exposed to 
Matrigel  and  we  found  substantial  decrease.  To  assess 
whether differentiation to mature hepatocyte morphology 
required DNA synthesis, we added 20 mM hydroxyurea. 
This has been shown to abolish scheduled semiconserva- 
tive DNA synthesis in hepatocytes (Michalopoulos et al., 
1978) by inhibiting ribonucleotide reductase. Hydroxyurea 
was  added  to  cultures  before the  Matrigel  overlay and 
maintained throughout the next 5-d period. DNA synthe- 
sis was decreased down to 3.93% of the control (without 
hydroxyurea) in the cultures maintained in the absence of 
Matrigel and down to 6.27% of control (without hydroxy- 
urea) in the cultures maintained in the presence of Matri- 
gel. Though DNA synthesis was decreased down to 6.27% 
of control (+Matrigel, no hydroxyurea) levels, the conver- 
sion of the proliferating hepatocytes to mature hepatocyte 
morphology was entirely unaffected and involved the en- 
tire population (data not shown). 
HGFISF (but Not TGFa or EGF) Induces Proliferating 
Hepatocytes  to Differentiate into DuctularlAcinar 
Stntemres in Type I Collagen Gels 
Hepatocytes maintained between two collagen gel layers 
retain their morphology and differentiation for prolonged 
time periods (Michalopoulos et al., 1975; Dunn et al., 1992; 
Michalopoulos et al.,  1993).  This is typical of many other 
epithelial  cell  types (Hamamoto et  al.,  1988).  We  have 
shown in previous studies that hepatocytes maintained in 
collagen gel sandwiches in cultures with conventional me- 
dia  containing  HGF/SF  undergo  intense  proliferation, 
form prominent projections, and eventually become orga- 
nized in structures reminiscent of the hepatic plates (Mich- 
alopoulos et al., 1993). We examined in this study the be- 
havior of hepatocytes maintained between two layers of 
collagen gel as previously described, but in the presence of 
HGM supplemented with either HGF/SF or EGF. We no- 
ticed that in the EGF supplemented media hepatocytes 
underwent the typical phenotypic transitions as described 
above. On the other hand, in hepatocytes in HGM supple- 
mented with HGF/SF alone, following expansion of cells 
identical in  appearance  to  the  proliferating hepatocytes 
described  above,  there  appeared  multiple  duct-shaped 
structures between days 10 and 15. These became promi- 
nent and encompassed most of the cells present in the cul- 
tures. Starting from approximately day 10 and by day 15 
most  of the  cells  in  the  culture  were  arranged  in  such 
ductular structures. The appearance of these structures is 
shown in Fig. 6 A. Histologic sections are shown in Fig. 6 B 
(light microscopy) and Fig. 6, C and D  (electron micros- 
copy). The structures had a ductular or acinar configura- 
tion. Some of the cells surrounding these structures were 
very attenuated and had light and electron microscopic ap- 
pearance identical to bile duct epithelium. Others however 
are larger and resemble more the ductular hepatocytes de- 
scribed in previous studies of in vivo models (Gerber et al., 
1983). The proliferation of cells (data not shown) under ei- 
ther EGF or HGF/SF in the collagen gel sandwiches was 
much less (<25%  at the highest peak) than that seen in 
the cultures on plastic coated with dry collagen. Most pro- 
liferation ceased by day 10 and the ductlike structures ap- 
peared  after cell proliferation had  ceased  (days  10-15). 
Ductular acinar structures were also noted in these cul- 
tures when HGF/SF and EGF were combined but were 
fewer than with HGF/SF alone. As with the Matrigel over- 
lay, addition of hydroxyurea to inhibit DNA synthesis (in- 
hibition down to 5.1% of control) did not affect the forma- 
tion  of  the  ductular  structures  (data  not  shown).  As 
described from previous studies (Fausto, 1994; Gerber et 
al.,  1983)  with  ductular  hepatocytes in  vivo, these  cells 
maintain  gene  expression  patterns  characteristic  of the 
ductular hepatocyte phenotype. Fig. 6 E demonstrates that 
these cells express bile duct characteristic cytokeratin 19 
(Sirica 1992, 1995). A small amount of albumin expression 
was also retained, consistent with the presence of hepato- 
cyte-like cells within  the  ductular  structures  (Fig.  6  D). 
Please note that the ductular cells maintain CK19 expres- 
sion in the nonproliferating state in contrast to the cells 
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lar/acinar structures in cultures 
kept  from  the  beginning  be- 
tween two type I collagen gel 
layers in the presence of HGF/ 
SF. Photograph takes from 15-d 
cultures.  (A)  Phase  contrast 
photomicrograph (100×) show- 
ing  the  appearance  of  the 
ductular structures surrounded 
by collagen fibrils. (B) Photo- 
micrographs (100×)  of paraf- 
fin sections of the  above  gels 
stained  with hematoxylin  and 
eosin. Note the heterogeneous 
size of the cells surrounding the 
ductules. (C and  D)  Electron 
micrographs of cells surround- 
ing the same lumen but in dif- 
ferent locations around the lu- 
men, The cells in Fig. 6 C have 
a  morphology  similar to  bile 
duct epithelium. The  cells are 
attenuated,  have long parallel 
contacts,  are  joined  by many 
desmosomes  and  have  abun- 
dant keratin intermediate  fila- 
ments. The cells in Fig. 6 D, on 
the other hand, resemble more 
the  hepatocyte  phenotype. 
They have more prominent cy- 
toplasm  with rough  endoplas- 
mic reticulum  and  mitochon- 
dria, densely stained secondary 
lysosomes and fewer filaments. 
(E)  Expression  of  cytoker- 
atins 18 and 19 increases in cul- 
tures with ductular/acinar struc- 
tures whereas albumin is only 
slightly expressed. 
differentiating  toward  the  mature  hepatocyte  lineage 
which cease expressing this bile duct marker (Fig. 8 D). 
Association of HGFISF and c-met 
Expression in Embryonic Liver with Formation of 
AcinarlDuctular Structures 
The  formation  of  acinar/ductular  structures  by  hepato- 
cytes occurs often in situations associated with hepatic de- 
velopment of neoplasia. In a recent review (Stamatoglou 
and Hughes, 1994) the formation of acinar/ductular struc- 
tures  during embryonic development was described  as  a 
stage preceding the formation of hepatic plates. In view of 
our findings mentioned above and also in view of recent 
findings showing impaired hepatic development and em- 
bryonic death  in  mice  homozygous for deletions  in  the 
HGF/SF gene (Schmidt et al., 1995), we studied expression 
of HGF/SF and c-met by in situ hybridization in relation to 
histology of the embryonic liver. Fig. 7 B shows the promi- 
nent  appearance  of acinar/ductular  structures  in  embry- 
onic hepatocytes at the time when there is high expression 
of HGF/SF and c-met (Fig 7, C and D) during rat liver em- 
bryogenesis. 
Sustained Growth and Population Expansion 
of Human Hepatocytes in HGM, in the Presence 
of HGFISF and EGF 
Though human hepatocyte cultures have not been charac- 
terized  as  extensively as  those  of the  rat,  the  literature 
available has shown that these cells also undergo a limited 
round of DNA synthesis after stimulation by growth fac- 
Block et al. Hepatocyte Growth,  Biomatrix  and Growth  Factors  1143 Figure Z  (A, C, and D) Serial sections through a rat embryo at day 16 of gestation. A is a frozen section stained by hematoxylin and 
eosin. C and D are dark-field photomicrographs of in situ hybridization  with anti-sense riboprobes for HGF/SF (C) and c-met (D). The 
expression of both HGF/SF and c-met is prominently localized over the embryonic liver (shown with arrows) and also, but less so, over 
other embryonic structures. In B, a photomicrograph was taken from the embryonic liver of C. Multiple ductular  structures  (one shown 
with two arrows) with characteristic  lumens are seen, surrounded by embryonic hepatocytes overlaid by silver grains indicating c-met 
expression. 
tors in culture (Ismail et al., 1991). We tested the response 
of human hepatocytes to HGF/SF and EGF in HGM me- 
dium.  Results  similar to those  described  for rat  hepato- 
cytes were  found  in  primary cultures  of human  hepato- 
cytes.  Variation  was  seen  between  cultures,  with  best 
results seen in preparations of higher than 60%  viability 
and donor age younger than 20 years (data not shown). 
Discussion 
Phenotype of  Proliferating Hepatocytes and Lineage 
Relationships  to Hepatocytes and Bile Ducts 
The behavior of parenchymal hepatocytes in standard pri- 
mary culture, including their phenotypic changes and their 
limited proliferation potential, has been described in many 
systems (for review see Michalopoulos et al.,  1986).  The 
loss of gene expression markers characteristic of mature 
hepatocytes, the decrease in C/EBPct and the increase in 
C/EBP[3 associated with proliferation, have also been de- 
scribed in earlier systems (Rana et al., 1994). The novel as- 
pect of our findings is that conditions have been defined 
that  allow  the  progeny  of  proliferating  hepatocytes  to 
clonally  expand  and  increase  their  population  size.  The 
unexpected finding is the rapid reversal to hepatocyte phe- 
notype in the absence of substantial DNA synthesis in the 
proper matrix and growth factor environment. More unex- 
pected is the capacity of these cells to generate ductular 
structures, also in the absence of substantial DNA synthe- 
sis. The issues to be discussed relate to the conditions that 
allow clonal growth, the nature of the phenotypic changes 
observed,  the  lineage  relationship  between  hepatocytes, 
proliferating  hepatocytes,  and  bile  duct  epithelium,  the 
role of HGF/SF as a determinant for formation of ductular 
structures from proliferating hepatocytes, and the implica- 
tion of these findings for hepatic embryonic development 
and recovery from fulminant hepatitis. 
Cell Populations in the Primary Cultures 
The main cell type in the early cultures is definitely the pa- 
renchymal hepatocyte. These cells are derived by standard 
two step collagenase perfusion of rat and human liver (Se- 
glen,  1976),  which  yields  98%  parenchymal  hepatocytes 
(Seglen,  1976).  The electron microscopic and phase con- 
trast pictures shown in Fig. 2 also demonstrate the hepato- 
cyte identity of these cells. Approximately 2% of the cells 
in a  standard  collagenase perfusion are not parenchymal 
hepatocytes.  They  comprise  a  mixture  of  Ito  cells,  bile 
duct  cells,  endothelial  cells,  and  Kupffer cells.  From  all 
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highly unlikely that Ito cells, endothelial cells, or Kupffer 
cells would be the source of the cell types seen in our pri- 
mary cultures at the end of cell proliferation at culture day 
10. The cells comprising our cultures at all times have a 
very high  expression of hepatocyte-associated transcrip- 
tion factors HNF1, HNF3, and HNF4, factors not known 
to be associated with either of the above three cell types. 
Bile duct epithelium on the other hand has been shown to 
express hepatocyte-associated transcription factors during 
liver regeneration  and  when  hepatocyte proliferation is 
suppressed by AAF (Nagy et al., 1994). Bile duct epithe- 
lium is one of the minor contaminants of the primary cul- 
tures estimated to be less than 0.5 % of the overall popula- 
tion  (Seglen,  1976).  In  view  of  the  findings  that  the 
proliferating hepatocytes (98% of the cells at start point) 
can give rise to a population massively composed of ductu- 
lar structures at day 10, we need to address the issue of 
whether the cells at day 10 are not derived from hepato- 
cytes but from proliferating bile duct epithelium (<0.5% 
of cells at start point). Careful examination of the quanti- 
tative findings of the data presented shows that it is impos- 
sible for such a minor contaminant to account for the find- 
ings. If only a minor population of cells was proliferating, 
then there should be a gradual increase of labeling index 
from <0.5%  to a progressively larger percentage by day 
10. This is not the case, however, as shown in Fig. 1 A. The 
labeling index is low by day 2 but it rapidly increases to 
~80% at day 4 and stays at that level until day 10. The nu- 
clear labeling at day 4  until day 10 is  diffuse. From the 
above considerations, it is mathematically evident that the 
cells at day 10 are derived from proliferation of the vast 
majority of the cells present at day 2, i.e., the parenchymal 
hepatocytes. 
Another issue which needs to be addressed is the per- 
centage of true hepatocytes which are capable of produc- 
ing clones of proliferating cells. After transfection of cells 
with lac Z, the single cells at day 3 shown in Fig. 2 F  are 
typical  parenchymal  hepatocytes  expressing  lac-Z.  The 
same type of cells give rise to patches of labeled cells at 
day 10. The distribution of cells positive for expression of 
lac-Z at day 3 was entirely random. Since overall the per- 
centage of lac-Z-expressing cells (~20%) did not change 
from day 3 to day 10, it is clear that the progeny of the lac- 
Z-expressing cells arranged in clusters at day 10 is derived 
from growth of the 20% of the cells labeled at day 3. Since 
98%  of the cells at day 3  are parenchymal hepatocytes, 
most of the lac-Z-expressing cells at day 10 must be de- 
rived  from parenchymal hepatocytes. The findings  with 
lac-Z-infected cells  also corroborate the conclusions we 
have reached by direct microscopic observation of the cell 
populations in the cultures. The morphologic changes as- 
sociated with cell proliferation are gradual and they affect 
the entire cell population. These changes have been de- 
scribed in the past for other primary cultures (Chapman et 
al.,  1973)  and  they primarily appear  as  gradual  loss  of 
granularity from the hepatocyte cytoplasm by phase con- 
trast. There is no evidence of selective cell loss of specific 
hepatocyte populations. 
As stated in the Results, the proliferating hepatocytes in 
the proper matrix and growth factor environment gener- 
ate mature hepatocytes or ductular structures even when 
DNA synthesis is completely abolished by addition of hy- 
droxyurea. The vast majority of the cells present as prolif- 
erating hepatocytes converts to either the ductular struc- 
tures or the mature hepatocytes under these conditions. 
This demonstrates that the proliferating hepatocytes, de- 
rived from the mature hepatocytes of the original inocu- 
lum,  can  become  mature  hepatocytes or  form  ductular 
structures. The molecular markers used demonstrate that 
the differentiated hepatocytes express albumin, respond to 
phenobarbitol by induction of cytochrome P450 and cease 
expressing CK19, an in vivo marker for mobile duct cells 
(Sirica 1992, 1995). 
The finding that hepatocytes can give rise to two types 
of progeny suggests that at least under culture conditions, 
some if not most of the hepatocytes can function as bipo- 
tential stem cells. Such cells are expected to give rise to 
hepatocytes and  ductular  type cells.  The term  "hepato- 
blast" (etymologically defined as cells that can give rise to 
liver) has been used to describe the embryonic cells that 
differentiate both toward hepatocytes and bile duct epi- 
thelium (Fausto et al., 1993). In adult rats such a term is 
not frequently applied. The closest cell type with a bipo- 
tential differentiation are the oval cells or their precursors. 
These are cells that emerge when liver is stimulated to re- 
generate but the proliferation of the normal hepatocytes is 
suppressed (Evarts et al., 1989).  Oval cells proliferate dif- 
fusely. They are often arranged in a ductular configuration 
and eventually differentiate to mature small hepatocytes 
when  the  inhibitory stimulus  is  removed  (Evarts  et  al., 
1989).  The findings of our study show that regardless of 
other cell types, mature hepatocytes can also give rise to 
cells that can behave as hepatoblasts. 
Transcription Factor Changes Associated with 
Proliferating Hepatocytes and Their Redifferentiation 
to Mature Hepatocytes 
Consideration of the changes in transcription factors also 
supports the comparison between our proliferating hepa- 
tocytes  and  hepatoblasts.  The  proliferating  hepatocytes 
express high levels of most transcription factors associated 
with the mature  hepatocyte phenotype (Tronche, 1992). 
Specifically C/EBPI3,  HNF1,  and  HNF3  remained  nor- 
mally expressed and HNF4 increased. HNF313 and HNF3et 
have been described as the earliest expressed liver tran- 
scription factors during embryonic development (Ang et 
al., 1993). C/EBPet levels are low during the early stages of 
embryonic development, when the other transcription fac- 
tors are expressed (Nagy et al.,  1994).  C/EBPeL decreases 
dramatically after stimulation of liver regeneration (Flodby 
et al., 1993)  or entry of hepatocytes into proliferation in 
primary culture (Mischoulon et al.,  1992).  Characteristic 
patterns of induction of the C/EBP family members in the 
sequence of ~, 13, ct have also been described in postnatal 
liver development (Diehl et al., 1994; Diehl and Yang, 1994). 
It is unclear, however, whether the absence of C/EBPc~ is 
the sole factor that significantly affects the phenotype of 
the cultured cells, since they still express abundant C/EBPI3. 
In most cases, C/EBP~ and C/EBPI3 show almost identical 
binding and activation properties, although Lee et al. (1994) 
have described a cooperative interaction with transcription 
factor Spl that occurs with C/EBPI3 but not C/EBPet. This 
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notype associated with the differential expression of C/EBPt~ 
and C/EBPI3, but not a drastic alteration in phenotype as- 
sociated with loss of C/EBPa expression. Loss of the dif- 
ferentiated phenotype might be more directly associated 
with high AP1  expression, which has been shown to di- 
rectly suppress activity of the albumin gene enhancer (Hu 
and Isom, 1994). The increase in AP1 and NFKB is charac- 
teristic of proliferating cells. Their levels in liver embryo- 
genesis or oval cell development have not been directly 
addressed, although it has been shown that liver develop- 
ment fails in mice homozygous for a deletion in c-los (Hil- 
berg et al., 1993). The elevated HNF4 expression is also of 
interest, because it is mostly due to a second band shift, 
slightly higher and  distinct from the  usual  HNF4 band. 
Other liver-enriched factors are expressed as multiple dis- 
tinct family members, but HNF4 has so far been described 
only as a single factor (Sladek et al., 1990; Xanthopoulos et 
al.,  1991).  The upper  band  could represent  a  transcrip- 
tional or posttranscriptional modification of HNF4, a new 
factor that binds the HNF4 site, or a heterodimer of HNF4 
with another factor. The doubleband HNF4 gel shift pat- 
tern is unique to these cultures. 
As  mentioned in  the  results,  several previous studies 
have  associated  increased  hepatocyte  differentiation  in 
culture with increase in levels of C/EBPu (Mischoulon et 
al.,  1992; Rana  et al.,  1994).  In these studies addition of 
Matrigel resulted in enhanced hepatocyte differentiation, 
increase  in  levels of C/EBPct  and  decrease in  levels  of 
AP1. In our study, there was no increase in C/EBPct when 
Matrigel  induced differentiation of proliferating hepato- 
cytes into mature cells. The reasons for this discrepancy 
are not clear. On the other hand, the decrease in AP1 and 
NFKB  levels  is  compatible  with  previous  literature,  in 
which both of these factors are associated with enhanced 
hepatocyte proliferation (Tewari et al.,  1992; Rana et al., 
1994). 
Media Components Important for Clonal Growth 
The components of the medium that allow these cells to 
proliferate beyond the limitations of the standard media 
are currently under further study. A  cell culture medium 
similar in many respects to ours was previously presented 
by Mitaka et al. (1992a,b, 1993a,b). This medium also con- 
tained nicotinamide but it allowed formation of only small 
colonies of cells which coexisted with mature hepatocytes 
in dense cultures. These colonies did not form when sparse 
cultures of hepatocytes were used  and expansion of the 
population comparable to the results presented in our pa- 
per was not demonstrated. The composition of HGM dif- 
fers from the medium described by Mitaka  et al.  (1991, 
1992a,b, 1993a,b) in many significant ways. The most im- 
portant difference may be the presence in HGM of satu- 
rated diferric transferrin. As shown in Table I B, when un- 
saturated  transferrin  is  used  instead  of  the  saturated 
diferric type, the growth of the cells was significantly in- 
hibited. Addition of iron did not substitute for the effect of 
diferric transferrin.  Another  important  difference is  the 
addition of glucose in HGM. Galactose alone, used in the 
medium by Mitaka  et al.  (1991,  1992a,b,  1993a,b) is not 
sufficient for full proliferative effects. We also added argi- 
nine in addition to ornithine. Arginine in past work was 
removed from hepatocyte media in order to prevent con- 
tamination of cultures by nonparenchymal cells (Leffert et 
al.,  1977).  As  the  proliferating hepatocytes lose  specific 
hepatocyte related functions, it is likely that the pathways 
generating  arginine  through  urea  cycle would  diminish 
their activity or disappear altogether. Thus the absence of 
arginine might also be rate limiting for the growth of the 
proliferating hepatocytes. Differences in the detail compo- 
sition of trace elements etc. cannot be deduced from the 
existing publications but they also may be critical. We also 
found, as did Mitaka  et al.  (1991, 1992a,b, 1993a,b) that 
DMEM  supports  growth  of hepatocytes more  than  the 
standard MEM (data not shown). 
Role of Diferric Transferrin and Nicotinamide 
The role of diferric transferrin and nicotinamide in main- 
taining  hepatocyte  growth  and  function  is  well  docu- 
mented. Nicotinamide was shown in the past to promote 
maintenance of cytochrome P450 types in hepatocyte cul- 
tures (Paine et al., 1979), inhibit the expression of some fe- 
tal markers such as GGT (Rosenberg et al., 1982) and pro- 
long hepatocyte function maintenance in primary culture 
(Inoue et al.,  1989).  It was also shown to have effects on 
hepatocyte DNA repair (Althaus et al., 1980) as well as to 
prolong hepatocyte proliferation in standard media (Mi- 
taka et al., 1991).  The mechanism mediating these effects 
is  not  clear. Nicotinamide  appears  to  not  be  used  as  a 
source of replenishment of NAD  and NADP in isolated 
hepatocytes (Bender and Olufunwa, 1988). A potential in- 
teraction between NAD and diferric transferrin appears to 
occur at the hepatocyte plasma membrane (Morre et al., 
1991).  These studies  have  shown  that  most  of the  iron 
(70%) in hepatocytes exist in an extracellular pool of di- 
ferric transferrin bound to its plasma membrane receptor. 
It participates in mediating plasma membrane redox activ- 
ities with  a  nicotinamide adenine dinucleotide (NADH) 
reductase and together the two are crucial in maintaining 
the functions of the Na+/H ÷ antiport, a channel involved 
at  the  early  steps  of stimulation  of DNA  synthesis  by 
growth factors. 
Role of the Matrix in Proliferating Hepatocyte Growth 
and Differentiation 
Whereas no major differences in growth rate based on ma- 
trix coating of the plates were seen, the matrix environ- 
ment seems to have a more defining role on the differenti- 
ation of the cells once growth ceased. Addition of Matrigel 
promoted  a  return  of the  differentiation to  the  mature 
hepatocyte phenotype. This is  in  agreement with  previ- 
ously described effects of Matrigel  causing induction of 
polarity and canalicular differentiation in nonproliferating 
hepatocyte cultures (Musat et al.,  1993).  The "spontane- 
ous"  return  to mature  hepatocytes seen in  old  cultures 
with focal fibroblast overgrowth is also probably in part 
matrix dependent. As mentioned above, the "fibroblasts" 
seen in hepatocyte cultures actually derive from Ito cells 
of the liver (Maher et al.,  1988), the cells responsible for 
most of the matrix production. It was recently shown that 
Ito cells express mRNA for collagen types III and IV as 
well as for laminin, whereas collagen type III, type I, and 
fibronectin mRNA were expressed by parenchymal hepa- 
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formed to fibroblast-like morphology also produce large 
amounts of collagen type I, fibronectin, and laminin. It is 
highly likely that the focally growing fibroblasts produce 
liver related matrix that directs the differentiation of the 
immature proliferating hepatocytes back to the mature pa- 
renchymal phenotype. The effect of Matrigel may be due 
to its high laminin content (Kleinman et al., 1982).  Other 
components of Matrigel, however, may be responsible for 
this effect. Further studies with matrix components will be 
performed to study the effects of specific matrix proteins. 
It should be noted that Ito cells synthesizing matrix play a 
crucial role in the differentiation of the oval cells back to 
mature hepatocytes. Ito cells grow together with the oval 
cells and provide the background on which the differentia- 
tion to hepatocytes occurs through production of matrix 
and growth factors (Evarts et al., 1993). 
HGFISF and Its Receptor as the Key Molecules 
Controlling Formation of  Acinar/Ductular Structures 
from Hepatocytes: Implications for Fulminant Hepatitis 
and Embryonic Development 
Acinar/ductular structures composed of cells with proper- 
ties intermediate between hepatocytes and bile ducts are 
very commonly seen during different aspects of growth of 
embryonic, adult  normal, and neoplastic liver.  Stamato- 
glou  and  Hughes  (1994)  have  documented  that  these 
structures are intermediate stages between apolar imma- 
ture hepatocytes and mature hepatocytes arranged in he- 
patic  plates.  Of the  various  growth  factors  used  in  our 
study the only one that induced formation of these struc- 
tures was HGF/SF. When EGF was added with HGF/SF 
the  frequency of acinar/ductular structures  substantially 
diminished. The association of HGF/SF with formation of 
ductular structures has been documented in several recent 
studies. The association of expression of the HGF/SF re- 
ceptor (MET) with formation of ductular structures was 
also recently shown in kidney derived cell lines (Monte- 
sano et al.,  1991), in the mammary gland (Tsarfaty, 1992; 
Soriano et al., 1995) and in nonparenchymal liver derived 
cell lines (Johnson et al.,  1993). EGF or TGFet alone did 
not  induce  these  structures  in  the  hepatocyte  cultures. 
These findings have relevance to the histology of fulmi- 
nant hepatic failure. Structures composed of ductular cells 
with hepatocytic markers are also seen at the end stages of 
fulminant hepatitis. When most of the hepatocytes die, the 
only proliferating cells left are the "ductular hepatocytes" 
arranged in ductular structures near residual portal triads. 
Independent  studies  have  shown  that  during  the  same 
stage of fulminant hepatitis when ductular hepatocytes ap- 
pear, plasma HGF/SF levels are extremely high (Tsubou- 
chi et al., 1989). Our findings suggest that the acinar/ductu- 
lar structures seen in fulminant hepatitis are induced by 
the extremely high levels of HGF/SF in the plasma. Since 
previous studies (Evarts et al., 1989; Vandersteenhoven et 
al.,  1990) have shown that these cells can become hepato- 
cytes, it is conceivable that the very high levels of HGF/SF 
in the plasma  block further differentiation of these cells 
into mature hepatocytes, thus inhibiting liver regeneration 
and causing the irreversible hepatic failure associated with 
the high mortality of this syndrome. 
In a recent publication it was shown that lack of HGF/ 
SF is critical for embryonic development and that one of 
the key organs whose growth was drastically inhibited was 
liver  (Schmidt  et  al.,  1995).  Homozygous null  mice  for 
HGF/SF died at day 16.5 of gestation. The photographs of 
Fig. 7  showing the strong expression of HGF and c-met 
mRNA in embryonic liver were taken from rat embryos at 
day 18.  The studies  by Stamatoglou and  Hughes  (1994) 
show that appearance of ductular/acinar structures in the 
embryonic hepatocytes at this stage is required for the for- 
mation of the mature hepatocyte phenotype. Our findings 
suggest that the reason for inhibition of hepatic embryo- 
genesis in the HGF/SF-null homozygous mice is the inabil- 
ity, in the absence of HGF/SF, to undergo the phenotypic 
transitions  from the diffuse unstructured parenchyma of 
apolar  embryonic hepatocytes  to  acinar  ductular  struc- 
tures, a transitional stage before the formation of mature 
hepatic tissue. 
Hepatocytes as the Cell of Origin for 
Hepatocytic Lineages 
The findings of this paper raise questions on the origin of 
multipotential cells often seen in the liver. These cells are 
seen in numerous conditions, both in experimental animal 
models as well as in human disease. They have been called 
oval cells in rodent carcinogenesis and ductular hepato- 
cytes in fulminant hepatitis in humans (Evarts et al., 1989; 
Gerber et al., 1983). The tendency of these cells to aggre- 
gate and form ductular structures has made most of the 
workers in the field believe that the bile ductular or peri- 
ductular cells are the origin of these populations. The find- 
ings in this paper clearly demonstrate that mature hepato- 
cytes can also give rise to such cells. We have shown that 
the immature cells derived from hepatocytes can multiply 
and expand in a  clonal fashion. Additionally, these cells 
have markers of gene expression that relate to both hepa- 
tocytes and bile ducts. We also show that these cells can 
enter  back  into  differentiation  pathways  that  can  lead 
back to hepatocytes or to formation of ductular structures. 
Matrix components such  as laminin and type I  collagen 
and growth factors such as HGF/SF and EGF and TGF~t 
appear to participate in the control of these transitions. 
The transcription factor changes associated with this tran- 
sition  from mature  hepatocytes to proliferating hepato- 
cytes with apparent bipotential growth are rather conser- 
vative. Loss of C/EBPa and increase in NFKB and AP1 are 
the major changes observed. The other hepatocyte specific 
factors (HNF1, HNF3, HNF4) continue to be present. The 
presence of hepatocyte specific transcription factors at the 
same time as the cells express bile duct specific (CK19) 
and  rat  liver stem  cell specific (CK14)  (Bisgaard  et al., 
1994) cytokeratins also underscores the bipotential nature 
of these cells. The expression of a-fetoprotein is also asso- 
ciated with the multipotential stem cells (Sell, 1994). The 
emergence of acinar/ductular structures from hepatocytes 
clearly suggests that hepatocytes, at least in part, can ac- 
count for the origin of the multipotential cells seen in liver. 
This is  consistent with previous findings with transgenic 
animals in which hepatocytes have been shown to have al- 
most unlimited clonal potential (Rhim et al., 1994), though 
the transcription factor profile of these cells participating 
in the formation of hepatocytic clones in vivo has not been 
described. It is not clear from our findings, whether hepa- 
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ating such cells. Most of the studies suggest that periportal 
hepatocytes  are  more  likely  to  enter  into proliferation. 
Ductular/acinar structures are seen more commonly in the 
first  acinar  zone  (periportal).  Detailed  dissection  of the 
periportal and pericentral hepatocytes by established tech- 
niques needs to be pursued to further study this issue. The 
standard  collagenase  perfusion  used  in these  studies  re- 
covers  >90%  of all the hepatocytes present in the liver 
and  does  not  allow  for  this  distinction  to  be  made. 
Whether all hepatocytes can give rise to such cells with bi- 
potential differentiation  remains  unclear. The  data from 
Fig.  1 A  and 2, F and G suggest that the majority of hepa- 
tocytes can give rise  to cells with bipotential differentia- 
tion. Our findings cast hepatocytes and HGF/SF in a new 
role in which cellular phenotypic transitions governed by 
matrix and maintained by morphogenetic effects  induced 
by high levels of HGF/SF provide new pathways for liver 
injury repair and embryonic development. The system de- 
scribed in this study allows for the first time for clonal ex- 
pansion of rat and human hepatocytes, and it should be of 
relevance to studies using hepatocytes as vehicles for gene 
therapy or as cells for the build up of artificial  liver de- 
vices. 
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